No Data
China Isotope & Radiation Corporation (01763.HK) completed the issuance of RMB 500 million in corporate bonds for technological innovation.
Gelonghui, September 7 — China Isotope & Radiation Co., Ltd. (01763.HK) announced that, in accordance with the "Notice on the Public Offering of Science and Technology Innovation Corporate Bonds (
China Isotope & Radiation Corporation (01763) plans to issue technology innovation corporate bonds worth up to RMB 500 million.
China Isotope & Radiation Corporation (01763) announced that its 2026 public issuance of technology innovation corporate bonds to professional investors (Tranche 1), abbreviated as "26 CIR K1" with bond code 246015, will have an issuance size of no more than RMB 500 million (inclusive). Each bond has a face value of RMB 100 and an issue price of RMB 100 per bond. The indicative range for the coupon rate is 1.20%-2.20% (inclusive of both bounds).
CIRC To Go Ex-Dividend On October 5th, 2026 With 0.11492 HKD Dividend Per Share
August 31st (Beijing Time) - $CIRC(01763.HK)$ is trading ex-dividend on October 5th, 2026.Shareholders of record on October 6th, 2026 will receive 0.11492 HKD dividend per share on November 27th, 2026
China Isotope & Radiation (1763.HK): Revenue Grows Steadily; Innovation and R&D Accelerate
[Event]Company Announcement: As of June 30, 2026, the interim results show
China Isotope & Radiation Corporation (01763) plans to invest RMB 400 million in a nuclear technology application industry fund.
China Isotope & Radiation Corporation (01763) announced that on August 28, 2026, the Company’s Board of Directors approved the entry into a partnership agreement with China National Nuclear Corporation, CNNC Capital, CNNC Fund, National Industrial Investment Fund, Zhejiang Provincial Venture Capital Guidance Fund, Jiaxing Changchuang Industrial Investment, and Haiyan County State-owned Capital Investment. The total committed capital contribution by the partners is intended to be RMB 3 billion, with the Company intending to contribute RMB 400 million, representing a 13.33% stake.
China Isotope & Radiation Corporation (01763) appoints Li Penghui as General Manager of the Company.
China Isotope & Radiation Corporation (01763) announced that Mr. Zhang Junqi has resigned from his positions as Executive Director, member of the Board’s Strategy Committee, and member of the Board’s Science and Technology Innovation Committee due to adjustments in his job responsibilities, effective August 28, 2026. Mr. Zhang Junqi has also resigned from his position as General Manager of the Company for the same reason, effective August 28, 2026. Following his resignation, Mr. Zhang will no longer hold any position within the Company. On August 28, 2026, the Board resolved to appoint Mr. Li Penghui as General Manager of the Company.